Posts Tagged ‘labopharm’
Labopharm Reports Results For Phase III Study On Twice-daily Tramadol-acetaminophen Formulation
Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) announced the results of its recently completed North American Phase III clinical trial for its twice-daily formulation of tramadol and acetaminophen (study 06CCL3-001). Study 06CCL3-001 was a multi-centre, randomized, double-blind, parallel-arm study that compared the efficacy and safety of Labopharm’s twice-daily tramadol-acetaminophen formulation to placebo in the treatment of moderate to severe acute low back pain.
Rx Drug Compare
Translator
By N2H